American Airlines & Qantas JV to receive tentative U.S. approval
By Akshay Kedari  Date: 2019-06-03

American Airlines & Qantas JV to receive tentative U.S. approval

The U.S. Transportation Department would reportedly provide tentative approval to a proposal by American Airlines and Qantas Airways to run a joint venture, claimed sources close to the deal.

As per trusted sources, the department is projected to issue an order tentatively sanctioning the joint business agreement and tentatively providing antitrust immunity. The order, which is expected at the earliest, would depend on public comment, and will possibly include conditions to shield competition and permit government oversight of the venture.

Shannon Gilson, American Airlines spokeswoman said in a statement that the airline believes it has made a convincing case regarding the customer benefits of the joint venture, with no opposition raised against the proposal. Gilson further mentioned that the company is hopeful the joint venture with Qantas will be approved.

In 2016, the application for the joint venture covering Australia, New Zealand, and the United States was tentatively rejected by former President Barack Obama’s administration owing to opposition from rival carriers JetBlue Airways and Hawaiian Airlines.

In 2018, the companies made their second attempt under the administration of President Donald Trump for a project that would allow them to coordinate prices and schedules. The revised application reportedly made substantial changes including the elimination of a provision that would have banned either carrier from codesharing with other carriers, cited sources familiar with the matter.

Moreover, in their 2018 application, the airlines claimed that the venture would reduce fares and enhance capacity as a more feasible third competitor, thus persuading other carriers to improve quality, schedules, and price.

Presently, both American Airlines and Qantas rely on codeshare agreements to make certain routes economically viable and on receiving final approval, the two would be able to offer more flights, even to cities not currently served by either, the companies stated.

For the record, U.S. regulators have approved a similar joint ventures for United and Air New Zealand in 2001 and the Delta Air Lines and Virgin Australia venture in 2011, reported sources.

Source Credit
https://www.cnbc.com/2019/06/03/us-set-to-grant-tentative-approval-to-american-airlines-qantas-venture.html

About Author

Akshay Kedari    

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

Fibonacci Brands acquires Darwin from Harvest Health & Recreation
Fibonacci Brands acquires Darwin from Harvest Health & Recreation
By Akshay Kedari

Fibonacci Brands has recently announced the acquisition of Darwin from Harvest Health & Recreation (HARV.CN) as its foundation brand. Fibonacci is a leading player in the international cannabis industry. According to James George, founder of Fib...

GVN adds EVIT Center and Chumakov as its new Centers of Excellence
GVN adds EVIT Center and Chumakov as its new Centers of Excellence
By Akshay Kedari

The Global Virus Network (GVN), an international coalition of medical virologists, has recently announced the addition of Australian and Russian researchers. GVN is adding the Center for EVIT (Emerging Viruses, Inflammation & Therapeutics) of th...

Wind Point Partners takes over RTIC to expand business portfolio
Wind Point Partners takes over RTIC to expand business portfolio
By Akshay Kedari

American private equity firm, Wind Point Partners has recently signed an acquisition deal with the one of the biggest direct-to-consumer (D2C) eCommerce providers of drinkware, RTIC. Reportedly, RTIC is Wind Point’s third acquisition of a famil...

Novartis reveals positive data from Phase III ORION trials of inclisiran
Novartis reveals positive data from Phase III ORION trials of inclisiran
By Akshay Kedari

Swiss multinational pharmaceutical firm, Novartis has recently announced results from its Phase III ORION-10 and -11 studies that focus on assessing the individual responses of patients on lowering low-density lipoprotein cholesterol (LDL-C) with inc...

Medtronic to acquire Companion Medical to expand diabetes business
Medtronic to acquire Companion Medical to expand diabetes business
By Akshay Kedari

Medtronic plc, the global leader in medical technologies, has reportedly announced that it is planning to acquire insulin pen manufacturer Companion Medical. The acquisition gives Medtronic access to Companion Medical’s ‘InPen’, wh...